Appropriate Use Criteria Lessons From Japan∗ by Hung, Olivia Y. et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S VO L . 7 , N O . 9 , 2 0 1 4
ª 2 0 1 4 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 4 . 0 6 . 0 0 5EDITORIAL COMMENTAppropriate Use Criteria
Lessons From Japan*Olivia Y. Hung, MD, PHD,y Habib Samady, MD,y H. Vernon Anderson, MDzP rofessional societies, including the AmericanCollege of Cardiology, have for many yearsdeveloped and periodically updated formal
guidelines that attempt to provide a comprehensive
review of available evidence for management of
certain clinical conditions. These guidelines are
distinctly structured documents and include recom-
mendations both for and against various practices.
For some treatments, including percutaneous coro-
nary intervention (PCI), it was observed that there
are wide variations in practice across many
geographic regions. It was further recognized that
there are gaps in a guidelines approach to under-
standing how PCI and other therapies could vary so
widely. In order to address these gaps and investigate
whether there might be overuse or underuse of
various procedures that carry both potential beneﬁt
as well as risk, the American College of Cardiology
established an appropriateness criteria working
group. This group’s ﬁrst task was to develop a meth-
odology for evaluating appropriateness of cardiovas-
cular imaging procedures (1). Other efforts quickly
followed, and in 2009, the initial appropriate use
criteria (AUC) for PCI were published (2). A revised
update of these came out in 2012 (3).
The AUC were developed as a schematic way
to provide guidance to clinicians on appropriately
selecting patients for PCI. The workgroup*Editorials published in JACC: Cardiovascular Interventions reﬂect the
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contents of this paper to disclose.methodically compiled a set of clinical scenarios and
then assigned scores (1 to 9) of relative “appropriate-
ness” for PCI to each scenario. This was an initial
attempt to encapsulate a complex clinical decision-
making process that assimilates the patient’s symp-
tom status, medical therapy, noninvasive stress test
results, and angiographic data. By pre-speciﬁed
design, the graded scenarios were grouped into
3 general categories, with scores 7 to 9 called
“Appropriate,” scores 4 to 6 called “Uncertain,” and
scores 1 to 3 called “Inappropriate.” However, the
choice and strength of the clinical scoring factors have
raised many questions. How refractory to medical
therapy should angina symptoms be before one can
offer a patient symptom relief with PCI? As thorny as
that question might be, the issue of noninvasive im-
aging as the ultimate determinant of signiﬁcant
ischemia and, by extension, general clinical risk has
sparked even greater disagreement among thoughtful
clinicians. Although there is little debate that at a
population level identiﬁcation of ischemia on stress
tests confers an adverse prognosis, the problem for
individual patients is that interpretation of these tests
for each person is highly variable and has substantial
false positive and false negative rates (4–7).
The AUC are beset by numerous additional difﬁ-
culties. To list just a few: 1) the evidence base is not
strong, with most of the criteria based upon “expert
opinion” derived from surveys of the clinical litera-
ture rather than from hard comparative science using
the speciﬁc written scenarios themselves; 2) the
scenarios are descriptive, but nonspeciﬁc, with only
about one-half of cases examined able to be classiﬁed
using them; 3) many or even most individual cases
are classiﬁed as Uncertain, which further underscores
the lack of clear guidance the AUC might otherwise
provide; and 4) the AUC are not validated (neither the
scored scenarios nor the group categories), and there
currently are no metrics nor method by which to
validate them.
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1011When these AUC were applied retrospectively to
clinical practice in the United States using >600,000
cases from the National Cardiovascular Data Registry
(NCDR), several important discoveries were made (8).
Acute PCI procedures were the majority of cases
analyzed (71%), with only a miniscule 1,770 cases
of >350,000 in the sample that could not be classi-
ﬁed. Essentially all acute PCI procedures (99%) were
classiﬁed as Appropriate. For nonacute PCI cases the
situation was different. Fully 41% (>100,000) of cases
in the sample could not be classiﬁed at all, and
therefore, nonacute PCI formed a minority (29%) of
cases analyzed. For nonacute PCI cases, 50% were
classiﬁed as Appropriate, 38% were Uncertain, and
12% were Inappropriate. The variation between hos-
pitals was quite broad, with the Inappropriate cate-
gory ranging from 0% of cases to 55%. Another
analysis of hospital-level data from NCDR using
>426,000 nonacute PCI procedures from 1,199 hos-
pitals conﬁrmed these ﬁndings (9). Here, 51% of the
procedures could not be classiﬁed, and the overall
rates for those that could were Appropriate in 50%,
Uncertain in 36%, and Inappropriate in 12%. The
variation between hospitals for the Inappropriate
classiﬁcation was again extremely broad (0% to 59%).
Other analyses using smaller datasets of nonacute PCI
in Washington State and New York State are consis-
tent with the ﬁndings from NCDR (10,11). Also noted
in all these datasets is that lack of stress test results
and not matching any written clinical scenarios were
the main reasons for inability to classify nonacute PCI
cases.SEE PAGE 1000Now comes a new study, in this issue of JACC:
Cardiovascular Interventions, that examines applica-
tion of the AUC to a large registry of 10,050 PCI pa-
tients treated in Japan over a 5-year period between
2008 and 2013 (12). Two interesting features of this
Japanese work are: 1) classiﬁcation of cases by both
2009 and 2012 AUC criteria; and 2) examination of the
trend in classiﬁcations over the 5-year interval. These
investigators found that 96% of PCI procedures per-
formed in acute settings were rated as Appropriate
using the 2009 AUC criteria, but this fell to 78% using
the 2012 criteria. Changes in clinical scenario ratings
accounted for this decrease. Nevertheless, the high
rates of Appropriate for the acute PCI procedures in
Japan are consistent with U.S. reports. For nonacute
PCI in Japan, the Inappropriate classiﬁcation was
given to 15% according to AUC 2009, and this
doubled to 31% according to AUC 2012. The analysis
by the 8 time subintervals from 2008 to 2013 shows
steady increases in the percentage of InappropriatePCI. So the major ﬁnding in this report is that a sub-
stantial and increasing number of nonacute PCI cases
in Japan are classiﬁed as Inappropriate using these
U.S. criteria. The reason appears to be that common
methods to assess the signiﬁcance of coronary disease
in contemporary Japanese practice are coronary
computed tomographic angiography (CCTA) and/or
measurement of fractional ﬂow reserve (FFR) during
invasive diagnostic angiography, both of which are
being used increasingly often. The AUC are predi-
cated on performing stress tests for determining
functionally signiﬁcant ischemia and not on these
alternative technologies. This situation requires
comment.
The ﬁrst issue is the evolving role of FFR. FFR
is based upon pressure wire measurements in a
coronary artery during a diagnostic catheterization
procedure. Originally, these measurements were
validated against myocardial perfusion imaging as a
correlative assessment for ischemia in the distribu-
tion of the tested coronary artery. However, FFR
has now gone beyond correlations with perfusion
imaging–assessed ischemia and arguably is the gold
standard for identifying lesion-speciﬁc ischemia (13).
It has now been validated in its own right as predic-
tive of future clinical events, and elective PCI
performed on lesions found signiﬁcant by FFR are
recognized as fully warranted procedures (13–15). Yet,
the current collection of guidelines for evaluating
patients for coronary disease specify that FFR mea-
surements are only justiﬁed in patients who are un-
dergoing Appropriate diagnostic catheterization (i.e.,
only after pre-catheterization stress tests have been
found abnormal), and then only on intermediate
lesions in arteries that correlate with the stress test–
derived ischemic territory (3,16,17). Japanese cardi-
ologists, like many of their U.S. counterparts, would
appear to disagree with this approach. Patients with
suspicion of CAD or with known stable ischemic heart
disease may get a diagnostic angiogram without pre-
procedure stress testing, with FFR performed on
signiﬁcant or borderline lesions, and then subsequent
PCI for FFR-positive lesions. Interestingly, when
these investigators (12) reclassiﬁed their CCTA-based
PCI cases from Inappropriate to Appropriate, they
found that the proportion of Inappropriate PCI still
increased over time. Because FFR use also increased
over the interval, it is likely that FFR-based cases
account for this ﬁnding. All of this suggests that
Japanese practice may be shifting as both technology
and the evidence base evolve (18).
The second issue of importance is the introduc-
tion and evolution of CCTA. This is now recognized
as a powerful anatomic tool with excellent
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1012speciﬁcity for identifying coronary disease. Although
not strictly a functional measure, even this concept
may be changing inasmuch as sophisticated ﬂuid
dynamics calculations can be made from the ana-
tomic data. This has led to efforts to derive a func-
tional CCTA-based FFR estimate (CTFFR), which has
been correlated to standard invasive FFR (19,20).
This may become appealing because it combines
anatomy with estimates of physiology, and a pro-
spective clinical trial is now underway comparing
CTFFR to noninvasive imaging for risk-stratifying
patients with coronary disease (21). In addition, the
relevance of CCTA may expand as the concept of
“anatomic burden of disease” re-emerges as clini-
cally compelling. In a large registry of patients, the
extent and severity of coronary disease burden
determined by CCTA was successful in stratifying
mortality risk over 3 years of follow-up (22). The
COURAGE (Clinical Outcomes Utilizing Revasculari-
zation and Aggressive Drug Evaluation) trial in-
vestigators themselves have shown that anatomic
burden of coronary disease (assessed from standard
angiography) along with left ventricular function
were consistent predictors of future adverse clinical
events, whereas functional ischemic burden was not
(23). Unfortunately, in several guidelines, CCTA is
recommended only after prior stress testing has
been found abnormal (16,17).
This welcome report from Japan gives us pause
and reminds us that a wider view on the assessment
of coronary disease signiﬁcance is needed. Al-
though valuable information is obtained from exer-
cise stress testing, reliance on pre-procedure stress
tests for ischemia may not be the single most impor-
tant factor for justifying the appropriateness of PCI.Alternative technologies also have essential roles to
play. Indeed, the concept of combining anatomy with
lesion-speciﬁc physiology is very appealing, whether
using angiography plus FFR, positron emission to-
mography plus CCTA, or more recently, CTFFR
(19,20). A recent economic analysis suggests that
CTFFR may be superior to invasive angiography plus
FFR from a cost standpoint (24).
Although the AUC process is vitally necessary and
must continue to develop as an important method for
giving guidance to clinicians and for assessing clinical
practice, at the present, we must acknowledge these
criteria for what they are: an experimental research
tool for clinical studies. These “criteria” are not now
and never have been ready for widespread applica-
tion as deﬁnitive clinical practice, and they certainly
should not be used for any punitive or quasi-punitive
purposes to which they may be put (25,26). Until a
larger share of nonacute PCI cases can be classiﬁed,
and classiﬁed as something other than Uncertain or
the equally vague “May Be Appropriate,” the ability
of the AUC to inform clinicians (or anyone else) will
remain markedly limited. The current AUC should be
set aside from regular clinical practice, carefully
investigated as a research tool, and then vetted in the
clinical arena, which, to be complete and modern
as these investigators in Japan suggest (12), will
include all the available technologies in multiple
combinations.
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